Acromegaly – what are the signs, symptoms , causes and treatments of Acromegaly?

Growth hormone complications

Growth hormone complications

Acromegaly is a condition in which the body produces too much growth hormone, leading to the excess growth of body tissues over time.

Typical features include:

  • abnormally large hands and feet
  • large, prominent facial features
  • an enlarged tongue
  • abnormally tall height (if it occurs before puberty)

Growth hormone is produced and released by the pituitary gland, a pea-sized gland just below the brain.

When growth hormone is released into the blood, it stimulates the liver to produce another hormone – insulin-like growth factor 1 (IGF-1) – which causes growth of muscle, bones and cartilage throughout the body.

This process is essential for growth and repair of body tissues.

What happens in people with acromegaly?

Acromegaly is caused by excessive production of growth hormone.


This usually occurs as the result of a benign (non-cancerous) brain tumour in the pituitary gland called an adenoma, but rare cases have been linked to tumours elsewhere in the body, such as in the lungs and pancreas.

Although acromegaly does very occasionally run in families, most adenomas are not inherited – they usually develop spontaneously as a result of a genetic change within a cell of the pituitary gland. This genetic change switches on a signal that tells cells in the pituitary gland to divide and secrete growth hormone.

The tumour almost never spreads to other parts of the body, but it may grow to more than 1cm in size and compress the surrounding nerves and normal pituitary tissue, which can affect the production of other hormones, such as thyroid hormones released from the thyroid gland.

Who is affected

It’s not clear exactly how many people are affected by acromegaly, although it’s been estimated that around 4 to 13 in every 100,000 people may have the condition.

This means there is likely to be between 2,500 and 8,300 people in the UK with the condition.

Acromegaly can affect people of any age, but it is rare in children. The average age at which people are diagnosed is around 40-45.

Problems caused by acromegaly

Acromegaly can cause a wide range of symptoms that tend to develop slowly over time.

Typical symptoms include:

Some of the above symptoms are the result of the tumour compressing nearby tissues – for example, headaches and vision problems may occur if the tumour squashes nearby nerves.

If you think you have acromegaly, see your GP straight away. Acromegaly can usually be successfully treated with brain surgery and medication, but early diagnosis and treatment is important to prevent the symptoms getting worse and to reduce your chance of getting complications.

Possible complications

If acromegaly is left untreated, you may be at risk of the following health problems:

Left untreated, these complications can become serious and fatal.

Diagnosing acromegaly

Blood tests

If your doctor suspects acromegaly from your symptoms, they will order blood tests to measure your levels of human growth hormone.

Levels of growth hormone naturally vary from minute to minute as it is released from the pituitary gland in spurts. Therefore to accurately diagnose acromegaly, growth hormone needs to be measured under conditions that normally suppress growth hormone secretion.

To ensure an accurate result, you may be referred to a hospital doctor for a glucose tolerance test. This involves testing your blood after drinking a solution or drink containing the sugar glucose.

In most people, drinking the glucose solution will suppress the release of growth hormone, but in people with acromegaly, the level of growth hormone in the blood will remain elevated.

Your doctor will also measure your level of IGF-1, which should increase with the level of growth hormone. An elevated IGF-1 level almost always indicates acromegaly.

Brain scans

You may then have a magnetic resonance imaging (MRI) scan of your brain to locate and define the size of the pituitary gland tumour causing your acromegaly.  A computerised tomography (CT) scan can be carried out if you are unable to have an MRI scan.

Treating acromegaly

Treatment aims to:

  • reduce excess growth hormone to normal levels
  • relieve the pressure the tumour is exerting on the surrounding structures
  • treat any hormone deficiencies
  • improve the symptoms of acromegaly

This is usually achieved through surgical removal of the tumour and medication.

Brain surgery

In most cases, surgery is recommended to remove the adenoma from your pituitary gland. This is effective in most people, although sometimes the tumour is too large to be removed completely.

Under a general anaesthetic, the surgeon will make an incision inside your nose or behind your upper lip to access the gland. An endoscope (a long, thin, flexible tube that has a light source and a video camera at one end) and surgical instruments are then passed through the incisions to remove the tumour.

Removing the tumour promptly relieves the pressure on the surrounding structures and leads to a rapid lowering of growth hormone levels. Facial appearance and swelling often improve within a few days.

Possible complications of surgery include damage to the healthy parts of the pituitary gland, leakage of cerebrospinal fluid (which surrounds and protects the brain), and  meningitis, though this is rare. Your surgeon will discuss these risks with you and answer any questions you have.

Radiotherapy

If surgery is not possible, or surgery and medication do not cure the condition, radiotherapy aimed at the adenoma may be an option.

This can eventually lead to a reduction in growth hormone levels, although it may not have a noticeable effect for several years and you may need to take medication in the meantime.

There are two main types of radiotherapy for acromegaly:

  • Stereotactic radiosurgery – where a high-dose beam of radiation is precisely aimed at the tumour, requiring you to wear a rigid head frame to keep your head still. This can sometimes be done in a single session.
  • Conventional radiotherapy – where the tumour is targeted with external beams. This can potentially damage the surrounding pituitary gland and brain tissue, so small doses of radiation are given over four to six weeks, giving normal tissue time to heal in between treatments.

Stereotactic radiosurgery is generally preferred to conventional radiotherapy because it minimises the risk of damage to nearby healthy tissue, although it is not always widely available.

Radiotherapy can have a number of side effects. For example, the treatment will often cause a gradual decline in the production of other hormones from your pituitary gland, so you’ll usually need to take hormone replacement therapy for the rest of your life. There’s also a risk it will impair fertility. Speak to your doctor about the risks involved.

Bowel cancer screening

There is some evidence acromegaly may increase your risk of bowel cancer, so guidelines recommend having a colonoscopy when you are diagnosed with the condition, and regular colonoscopy screening from the age of 40.

A colonoscopy is an examination of your entire large bowel using a type of endoscope called a colonoscope that is inserted into your bottom. See bowel cancer tests for more information about what a colonoscopy involves.

Outlook

Treatment is often effective at stopping the excessive production of growth hormone and improving problems caused by the condition. Treatment can also increase life expectancy to around that of someone without acromegaly.

Some treatments can take a long time to have a noticeable effect and you may need to take medication for a long period of time.

After treatment, you’ll need regular follow-up appointments with your specialist for the rest of your life. These will be used to monitor your pituitary function, check you are on the correct hormone replacement treatment, and to ensure the condition does not return.

Without treatment, acromegaly can cause long-term problems and may reduce life expectancy by a number of years.

[Original article on NHS Choices website]

Consumers often receive out-of-date diet and health advice – do you agree?

Out of date advice?

Out of date advice?

Experts representing public health nutrition, preventive medicine, and consumer behaviour call for better health information.

European consumer research* conducted by the Institute for Scientific Information on Coffee (ISIC) to better understand beliefs, behaviours, and knowledge regarding coffee and a healthy diet, suggests consumers are confused about the potential health benefits of coffee, in part because the information they are receiving is not always in line with the latest science.

Moderate consumption of coffee at 3-5 cups per day has been associated with a range of desirable physiological effects such as improved alertness[1] and a reduced risk of type 2 diabetes[2,3], cardiovascular disease[4,5] and cognitive decline[6,7]. It can be consumed as part of a healthy balanced lifestyle, providing fluid and small amounts of some nutrients, such as potassium, magnesium and niacin. Pregnant and breastfeeding women are also advised by EFSA that caffeine intakes of up to 200mg (2 cups of coffee) per day are considered safe for the foetus/infant[8].


To further explore the consumer research findings, ISIC invited three eminent experts representing public health nutrition, preventive medicine, and consumer behaviour to review and discuss the latest scientific research on coffee and health, consumers’ knowledge and attitudes, and the role of healthcare professionals in disseminating healthy diet advice.

Conclusions from the roundtable:

·         Many consumers are not aware of the potential health effects of coffee, with 49% believing it may cause health problems.

·         Consumers often obtain out-of-date information on coffee and health from the internet and media sources (such as magazines and TV) but also from healthcare professionals e.g. 56% of the survey respondents who believed that “drinking coffee increases the risk of heart disease” heard this either online, in a newspaper/magazine, or on TV and 16% heard this from a doctor, nurse, or dietician.

·         Consumers may not always distinguish between coffee and caffeine, viewing it purely as a stimulant, missing out on coffee’s specific components and potential physiological benefits.

Key Recommendations

·         HCPs need up-to-date accurate, science-based information that healthcare professionals can discuss and share with their patients.

·         Informing patients about the latest science on coffee could result in behavioural change as consumers begin to appreciate its role within a healthy diet.

·         More education is needed to help the general public identify reliable/unreliable information from media/online sources.

The experts were:

·         Prof Chris Seal: Professor of Food and Human Nutrition, and Chair of Board of Studies, Food & Human Nutrition BSc at Newcastle University, UK.

·         Prof Lluís Serra-Majem: Director of the Research Institute of Biomedical and Health Sciences, Las Palmas de Gran Canaria University, Spain

·         Dr Agnès Giboreau:  Research Director, Institut Paul Bocuse, France

Professor Lluís Serra-Majem commented: “We are increasingly seeing consumers obtain health information from the internet and media sources rather than from qualified healthcare professionals. We need to improve access to information for all parties, as in my experience healthcare professionals sometimes impart their own opinions to patients, even if this is only based on personal experience, not scientific fact.”

Professor Chris Seal continued: “Whilst key dietary messages such as ‘consume five portions of fruit and vegetables a day’ and ‘eat less fat, salt and sugar’ are well known, many remain unaware of the potential health benefits of coffee. Helping people to understand how regular daily consumption of 3-5 cups of coffee might reduce their risk of certain diseases and long-term health conditions could prompt behaviour change.”

Dr. Agnès Giboreau said: “Coffee is often drunk to accompany or conclude a meal therefore it’s important that consumers understand the value of what they’re drinking as well as eating. Personal habits, such as the way someone takes their coffee, are often based on experiences and cultural backgrounds, and so changing behaviour must be consistent with culture, beliefs and typical habits.”

There was unanimous agreement amongst the expert panel that healthcare professionals, including dietitians, nutritionists and clinicians, are the best source of reliable, scientifically-grounded information on healthy lifestyles for consumers. They are also best placed to advise consumers on where to find reliable information on coffee and a healthy diet. Healthcare professionals could also encourage consumers to analyse the credibility and validity of health information they read or see in the media. It was agreed that this group of professionals should be supported with regularly-updated educational material to ensure that the advice they give is accurate.

 

* 4119 respondents across 10 European countries were surveyed by ISIC through an independent research company in November 2015.

To read the roundtable report, ‘The good things in life: coffee as part of a healthy diet and lifestyle’ click here.

 

References

1.    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011) Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA Journal;9(4):2054

2.    Huxley R. et al. (2009) Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus. Arch Intern Med, 169:2053-63.

3.    Zhang Y. et al. (2011) Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study. Nutr Metab Cardiovasc Dis. 21(6):418-23.

4.    European Heart Network, ‘European Cardiovascular Disease Statistics 2012’ Available at: http://www.ehnheart.org/cvd-statistics.html

5.    Ding M. et al (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 129(6):643-59

6.    Santos C. et al. (2010) Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis, 20(1):187-204

7.    Palacios N. et al. (2012) Caffeine and Risk of Parkinson’s Disease in a Large Cohort of Men and Women. Movement Disorders, 1;27(10):1276-82

8.    EFSA (2015) Scientific Opinion on the Safety of Caffeine, EFSA Journal, 13(5):410

Strategies for dealing with fear and anxiety caused by a chronic medical condition.

Strategies for dealing with fear and anxiety caused by a chronic medical condition.

I came across this fascinating infographic just now and felt I should share it with your all.

While it as written for people with multiple sclerosis but it is very suitable for other conditions such as diabetes, rheumatoid arthritis and fibromyalgia.

Do feel free to share with anyone you feel may be interested.


Multiple Sclerosis Strategies for Coping with Fear and Anxiety

From Visually.